C12N 2710/14032
Use of virus as therapeutic agent, other than vaccine
Official title: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N2710/14032 (Use of virus as therapeutic agent, other than vaccine) appears on 3 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 5
- Assignees
- 2
- Inventors
- 8
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Therapeutic viral microparticles for promoting stent biofunctionality and wound healing in vertebrate individuals2 Jun 2026US 12,642,831 B2MangoGen Pharma, Inc.
- Therapeutic viral microparticles for promoting stent biofunctionality and wound healing in vertebrate individuals9 Aug 2022US 11,406,676 B2MangoGen Pharma, Inc.
- Therapeutic viral microparticles for promoting stent biofunctionality and wound healing in vertebrate individuals9 Oct 2018US 10,092,607 B2MangoGen Pharma, Inc.
- Therapeutic viral microparticles for promoting stent biofunctionality and wound healing in vertebrate individuals30 Nov 2023US 2023/0381255 A1MangoGen Pharma, Inc.
- Pesticidal combinations of yersinia and insect viruses18 Nov 2021US 2021/0352913 A1Novozymes Bioag A/S
- Therapeutic viral microparticles for promoting stent biofunctionality and wound healing in vertebrate individuals18 Apr 2019US 2019/0111092 A1MangoGen Pharma, Inc.
- Therapeutic viral microparticles for promoting stent biofunctionality and wound healing in vertebrate individuals4 Feb 2016US 2016/0030496 A1MangoGen Pharma, Inc.
- Methods for bladder cancer therapy using baculoviral vectors16 Jul 2015US 2015/0197773 A1
Most cited
By later US patents